Patents by Inventor Takashi Sekida

Takashi Sekida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230201333
    Abstract: Provided herein is an isolated polynucleotide, which encodes structural proteins nsp1, nsp2, nsp3 and nsp4 and a polypeptide comprising an antigenic protein fused to a signal sequence, a transmembrane domain and at least one peptide selected from CD4+ T cell epitopes and CD8+ T cell epitopes. The polynucleotide is useful for manufacturing a vaccine against virus infection, especially, COVID-19 infection, the treatment of a cancer and/or an inflammatory disease.
    Type: Application
    Filed: December 16, 2022
    Publication date: June 29, 2023
    Applicant: VLP Therapeutics Japan, LLC
    Inventors: Wataru AKAHATA, Jonathan F. SMITH, Jeffery Leo ALEXANDER, Takashi SEKIDA
  • Publication number: 20160120840
    Abstract: Method and composition for treating a nonerosive reflux disease in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a fatty acid derivative are provided.
    Type: Application
    Filed: October 28, 2015
    Publication date: May 5, 2016
    Applicant: SUCAMPO AG
    Inventors: Ryuji UENO, Takashi SEKIDA
  • Publication number: 20140171496
    Abstract: The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof.
    Type: Application
    Filed: February 7, 2014
    Publication date: June 19, 2014
    Applicant: R-Tech Ueno, Ltd.
    Inventors: Ryuji UENO, Tsuyoshi HABE, Takashi SEKIDA
  • Patent number: 8686035
    Abstract: The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof.
    Type: Grant
    Filed: August 12, 2004
    Date of Patent: April 1, 2014
    Assignee: R-Tech Ueno, Ltd.
    Inventors: Ryuji Ueno, Tsuyoshi Habe, Takashi Sekida
  • Publication number: 20080033036
    Abstract: The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof.
    Type: Application
    Filed: August 12, 2004
    Publication date: February 7, 2008
    Inventors: Ryuji Ueno, Tsuyoshi Habe, Takashi Sekida
  • Publication number: 20040225014
    Abstract: The present invention provides a method for treating ocular hypertension and glaucoma, using a 15-keto-prostaglandin compound having a ring structure at the end of &ohgr; chain. The method of the present invention induces substantially no hair growth, which is a known side effect of conventional prostaglandin ophthalmic compounds such as latanoprost.
    Type: Application
    Filed: February 12, 2004
    Publication date: November 11, 2004
    Applicant: SUCAMPO AG
    Inventors: Tsuyoshi Habe, Takashi Sekida
  • Patent number: 5912247
    Abstract: A quinazoline compound of the formula (I): ##STR1## wherein Z means a group of the formula: ##STR2## (X is CH.sub.2, CHOH, CHOCH.sub.3, or O, and n is 1 to 3), or a group of the formula: ##STR3## (A is H or CH.sub.3, and B is --CH.sub.2 OH, or ethyl having 1 or 2 OH, or propyl having 2 or 3 OH), or a salt thereof, which are useful as anti-tumor agent, and a pharmaceutical composition containing the compound as an active ingredient.
    Type: Grant
    Filed: August 20, 1997
    Date of Patent: June 15, 1999
    Assignee: Kanebo, Ltd.
    Inventors: Yoshikazu Jinbo, Tomohiro Miyasaka, Yoshiaki Ikeda, Takashi Sekida, Kei Naruse, Masayuki Ando, Shigeru Iwaki, Kohichiro Yoshino